TY - JOUR
T1 - Risks and Benefits of Clinical Diagnosis Around the Time of Dementia Onset
AU - Power, Melinda C.
AU - Willens, Victoria
AU - Prather, Christina
AU - Moghtaderi, Ali
AU - Chen, Yi
AU - Gianattasio, Kan Z.
AU - Grodstein, Francine
AU - Shah, Raj C.
AU - James, Bryan D.
N1 - Publisher Copyright:
© The Author(s) 2023.
PY - 2023/1/1
Y1 - 2023/1/1
N2 - Diagnostic delay in dementia is common in the U.S. Drivers of diagnostic delay are poorly understood, but appear related to misconceptions about dementia, stigma, concerns about autonomy, the nature of the diagnostic process, and provider-related factors. There is little quantitative evidence underlying cited risks and benefits of receiving a diagnosis around the time of dementia onset, including impacts on physical health, impacts on mental health, care partner interactions, costs of care, increased time for care planning, or earlier access to treatment. While various groups continue to push for reductions in diagnostic delay, realization of benefits and mitigation of harms will require new research on potential benefits and harms. Workforce and resource constraints, coupled with the expected growth in the number of persons living with dementia, may be a barrier to realization of potential benefits and mitigation of identified harms, which will require adequate access to providers, services, and supports.
AB - Diagnostic delay in dementia is common in the U.S. Drivers of diagnostic delay are poorly understood, but appear related to misconceptions about dementia, stigma, concerns about autonomy, the nature of the diagnostic process, and provider-related factors. There is little quantitative evidence underlying cited risks and benefits of receiving a diagnosis around the time of dementia onset, including impacts on physical health, impacts on mental health, care partner interactions, costs of care, increased time for care planning, or earlier access to treatment. While various groups continue to push for reductions in diagnostic delay, realization of benefits and mitigation of harms will require new research on potential benefits and harms. Workforce and resource constraints, coupled with the expected growth in the number of persons living with dementia, may be a barrier to realization of potential benefits and mitigation of identified harms, which will require adequate access to providers, services, and supports.
KW - caregiving and management
KW - clinical geriatrics
KW - cognitivie impairment
KW - dementia
KW - literature review
KW - public health/public policy
UR - https://www.scopus.com/pages/publications/85177682059
U2 - 10.1177/23337214231213185
DO - 10.1177/23337214231213185
M3 - Article
AN - SCOPUS:85177682059
SN - 2333-7214
VL - 9
JO - Gerontology and Geriatric Medicine
JF - Gerontology and Geriatric Medicine
ER -